Vedolizumab CAS NO.943609-66-3

We provide customized and high-quality Vedolizumab product for your project.

Vedolizumab is a monoclonal antibody developed by Millennium Pharmaceuticals for the treatment of ulcerative colitis and Crohn's disease under the trade name Entyvio. Vedolizumab binds to integrin α4β7 (LPAM-1) and blocks α4β7, displaying anti-inflammatory activity.